Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Assessment of Six-minute Walking Distance 6MWD Between High Altitude HA vs. Sea Level LA in Healthy Individuals H

31. August 2026 aktualisiert von: Silvia Ulrich Somaini

Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes

To study the effect of descent from high altitude (Quito Ecuador: 2850m) to sea level on six-minute walking distance and scores in healthy individuals, who live permanently >2600m.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

The aim of this research is to investigate the six-minute walking distance and scores before and after descent (high altitude near their living altitude vs. sea level) in healthy individuals, who permanently live at high altitude over 2600m.

Studientyp

Interventionell

Einschreibung (Geschätzt)

14

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

  • Name: Michael Furian, Prof. Dr. sc. ETH
  • Telefonnummer: +41442552220

Studienorte

      • Zurich, Schweiz, 8091
        • University Hospital of Zurich

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Beschreibung

Inclusion Criteria:

  • Adults aged 18-80 years and of all genders
  • Permanent residence > 2600 m
  • healthy: no self-perceived cardiopulmonary disease limiting daily activities
  • written informed consent to participate in the study

Exclusion Criteria:

  • Age <18 years or >80 years
  • Participants who cannot follow the study investigations
  • Participants permanently living < 2600m
  • Participants who traveled and stayed overnight at altitudes <2000 m in the past 4 weeks.
  • any self-perceived cardiopulmonary disease limiting daily activities

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Six-minute walking distance 6MWD at sea level
Assessment of the six-minute walking distance and scores near their resident altitude at 2850m followed by a descent from 2850m to sea level by bus with a stay for 7 days and again assessment of the same outcomes
Descent from 2850m to sea level with stay for 7 days

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Six-minute walking distance after 7 days at sea level
Zeitfenster: From high altitude (2850m) to day 5-7 at sea level
Difference/change in six-minute walking distance in meter (6MWD) between 2850m and Day 5-7 at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
SpO2 (%) at rest and end-exercise after 7 days at sea level
Zeitfenster: From high altitude (2850m) to day 5-7 at sea level
Difference/change in SpO2 (peripheral oxygen saturation) at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
Heart rate (beats per minute) at rest and end-exercise after 7 days at sea level
Zeitfenster: From high altitude (2850m) to day 5-7 at sea level
Difference/change in heart rate at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
Blood pressure (mmHg) at rest and end-exercise after 7 days at sea level
Zeitfenster: From high altitude (2850m) to day 5-7 at sea level
Difference/change in blood pressure at rest and end-exercise between 2850m and Day 5-7 at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
Dyspnea and leg discomfort sensation after 7 days at sea level
Zeitfenster: From high altitude (2850m) to day 5-7 at sea level
Difference/change in dyspnea and leg discomfort sensation (assessed with BORG-CR10-Scale, Category Rating 0-10 with 10 being the most dyspnea/leg discomfort) at rest and end-exercise between 2850m and 5-7 days at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
NYHA functional class (1-4) after 7 days at sea level
Zeitfenster: From high altitude (2850m) to day 5-7 at sea level
Difference/change in NYHA functional class (New York Heart Association Class I-IV, IV being the worst) at rest and end-exercise between 2850m and 5-7 days at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
Quality of life after 7 days at sea level
Zeitfenster: From high altitude (2850m) to day 5-7 at sea level
Difference/change in quality of life score (EmPHasis-10: Score with 10 questions and 0-50 points, higher scores indicating poorer quality of life) between 2850m and 5-7 days at sea level in healthy individuals
From high altitude (2850m) to day 5-7 at sea level
General well-being after 7 days at sea level
Zeitfenster: From high altitude (2850m) to Day 5-7 at sea level
Difference/change in general well-being (Visual Analog Scale 10cm: the higher, the worse) between 2850m and day 5-7 at sea level in healthy individuals
From high altitude (2850m) to Day 5-7 at sea level
Acclimatization-effect of six-minute walking distance (m) at sea level
Zeitfenster: From Day 2 to Day 5-7 at sea level
Difference/change in six-minute walking distance (6MWD) within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of SpO2 (%) at rest and end-exercise at sea level
Zeitfenster: From Day 2 to Day 5-7 at sea level
Difference/change in SpO2 (peripheral oxygen saturation) at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of heart rate (beats per minute) at rest and end-exercise at sea level
Zeitfenster: From Day 2 to Day 5-7 at sea level
Difference/change in heart rate at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of blood pressure (mmHg) at rest and end-exercise at sea level
Zeitfenster: From Day 2 to Day 5-7 at sea level
Difference/change in blood pressure at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of dyspnea and leg discomfort at sea level
Zeitfenster: From Day 2 to Day 5-7 at sea level
Difference/change in dyspnea and leg discomfort (assessed with BORG-CR10-Scale, Category Rating 0-10 with 10 being the most dyspnea/leg discomfort) at rest and end-exercise within a stay at sea level of 7 days (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of NYHA functional class (1-4) at sea level
Zeitfenster: From Day 2 to Day 5-7 at sea level
Difference/change in NYHA functional class (New York Heart Association Class I-IV, IV being the worst) at rest and end-exercise within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of Quality of Life at sea level
Zeitfenster: From Day 2 to Day 5-7 at sea level
Difference/change in quality of life (EmPHasis-10: Score with 10 questions and 0-50 points, higher scores indicating poorer quality of life) within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level
Acclimatization-Effect of general well-being at sea level
Zeitfenster: From Day 2 to Day 5-7 at sea level
Difference/change in general well-being (Visual Analog Scale 10cm: the higher, the worse) within a stay of 7 days at sea level (after descent from 2850m) in healthy individuals
From Day 2 to Day 5-7 at sea level

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Silvia Ulrich, University Hospital Zurich, Departement of Pulmonology
  • Hauptermittler: Rodrigo Hoyos, Hospital Carlos Andrade Marin of Quito, Ecuador

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

25. September 2026

Primärer Abschluss (Geschätzt)

4. Oktober 2026

Studienabschluss (Geschätzt)

31. Dezember 2026

Studienanmeldedaten

Zuerst eingereicht

17. August 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

31. August 2026

Zuerst gepostet (Tatsächlich)

3. September 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

3. September 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

31. August 2026

Zuletzt verifiziert

1. August 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • Ec_HAvsLA_6MWD_H

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

Data will be provided upon request and based on a clear intention reviewed by an ethical review board.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .